about
Comparison of mantoux and tine tuberculin skin tests in BCG-vaccinated children investigated for tuberculosisImproving vaccination uptake among adolescentsPublic stewardship of private for-profit health care in low- and middle-income countriesSafety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South AfricaPublic stewardship of private for-profit healthcare providers in low- and middle-income countriesEpidemiology of hepatitis A virus in Africa among persons aged 1-10 years: a systematic review protocol.Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment: a systematic review.The use of supplementary immunisation activities to improve uptake of current and future vaccines in low-income and middle-income countries: a systematic review protocolSafety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trialKnowledge, attitudes and practices on adolescent vaccination among adolescents, parents and teachers in Africa: A systematic review.Childhood tuberculosis: old and new vaccines.Isolation of non-tuberculous mycobacteria in children investigated for pulmonary tuberculosis.Culture-confirmed childhood tuberculosis in Cape Town, South Africa: a review of 596 cases.A blood RNA signature for tuberculosis disease risk: a prospective cohort study.HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette-Guérin vaccine.Structured approaches for the screening and diagnosis of childhood tuberculosis in a high prevalence region of South AfricaThe tuberculin skin test versus QuantiFERON TB Gold® in predicting tuberculosis disease in an adolescent cohort study in South AfricaThe novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults.Association of human TLR1 and TLR6 deficiency with altered immune responses to BCG vaccination in South African infants.Review of rotavirus studies in Africa: 1976-2006.Knowledge, attitudes and practices on adolescent vaccination among parents, teachers and adolescents in Africa: a systematic review protocol.Safety of licensed vaccines in HIV-infected persons: a systematic review protocol.Individual and contextual factors associated with low childhood immunisation coverage in sub-Saharan Africa: a multilevel analysis.Improving communication for immunisation in Africa: contribution of the Vaccines for Africa website.Advances in childhood immunisation in South Africa: where to now? Programme managers' views and evidence from systematic reviews.Vaginal microbicides for reducing the risk of sexual acquisition of HIV infection in women: systematic review and meta-analysis.Time to symptom resolution in young children treated for pulmonary tuberculosisModified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cellsStrengthening the expanded programme on immunization in Africa: looking beyond 2015.Making BCG vaccination programmes safer in the HIV era.Trends in the types and quality of childhood immunisations research output from Africa 1970-2010: mapping the evidence base.A bibliometric analysis of cancer research in South Africa: study protocol.Qualification of a whole blood intracellular cytokine staining assay to measure mycobacteria-specific CD4 and CD8 T cell immunity by flow cytometry.Increasing the value of health research in the WHO African Region beyond 2015--reflecting on the past, celebrating the present and building the future: a bibliometric analysisThe African Vaccine-Preventable Diseases Network: a vaccine advocacy initiativeHIV-specific gag responses in early infancy correlate with clinical outcome and inversely with viral loadDose-dependent immune response to Mycobacterium bovis BCG vaccination in neonates.A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected adultsHuman newborn bacille Calmette-Guérin vaccination and risk of tuberculosis disease: a case-control study.Higher human CD4 T cell response to novel Mycobacterium tuberculosis latency associated antigens Rv2660 and Rv2659 in latent infection compared with tuberculosis disease.
P50
Q21142696-331C1FC1-DEEB-47B3-89A0-91CCC0FF0C78Q24187430-7DBC2A5E-1DCA-44D6-B925-43787F1E467FQ24198091-1735968B-1677-446E-A734-AAB5331F31E6Q24647137-F967677C-7F93-47BA-99FD-04A9F50DEDB5Q26470453-1BAA331A-60A6-4E8E-B496-7CBADB6B02BFQ26784450-081EC635-CC75-45B7-B7E9-AFED20D28846Q26824866-26B2A5BF-EA9E-45E8-BF20-320907B69EB4Q26864948-0620DDA3-5CFC-4716-832F-8EF1964D5C85Q29620144-03D23621-4D98-430C-8B33-2760720B1934Q30249669-9372993D-61B2-4C9B-958D-22A5F1DF8D0AQ30362363-F62ABA56-C532-47CA-8564-38D1E8DA8746Q33267281-8B95F714-9311-43E1-9D82-8E22255B02D3Q33307793-C43997FA-BD94-48DB-B2F9-A7BE0CCD8C24Q33566308-4CED9110-3F88-470A-8E45-FBC9BB52F789Q33627000-B77F4510-84ED-48DF-99D8-CE1E18F4EEAEQ33793322-CC36A374-1886-487C-A001-B9FF5728397CQ33867491-7B6847F4-B7B4-4B34-BED8-E6FC3290CCC0Q33950119-E26B2798-A5DA-4C12-A154-9580768C187DQ33996621-542779A2-D966-491E-B208-9A5E7D8FB7D7Q34129656-D90F24A8-80B5-403D-B5D4-2FB9DDB55276Q34167964-AF7A9863-9877-45D8-9D7C-5DB819DC7336Q34178074-62B0EE16-3830-4BAB-9CD6-AEA9D5C142F2Q34291411-D294B6E6-7C83-4728-B5C7-B447E172B692Q34320937-69219D42-3685-41C0-BFD8-62E79163528CQ34360356-0FFF7B86-0055-4BA2-A3D2-80FD0DE33504Q34468210-482DB934-65D8-4147-93BD-0B15D70D9F4AQ34498437-5FC80380-6013-4409-AFDC-1C3D126E2CD4Q34605490-5CC30FF8-5398-4B7E-9859-D424A757EB3EQ34633888-8AB2EC94-4D0E-4201-88D9-3B3A8C3C9948Q34822215-CF1DEA6C-E001-4DB2-AC1A-A5F23503C6D5Q35086820-CC90BFB6-3375-4497-B3F8-1D0914ED8B30Q35088880-E2A9E82F-4272-49B7-B7B7-116C2C87392FQ35117812-5DC81298-2CCA-4EA3-975C-0FC4FB82912DQ35179927-C0C3F72E-35E8-412F-B1AE-0819CB0E7F5FQ35444613-9553A92A-53B1-40C7-BE0A-C76B9C4FBDCEQ35581936-E8B46B89-1DAE-41FF-82ED-01924B1FB1C4Q35636085-E252C994-EA0B-44BB-A81B-FA325F223B3DQ35889153-46857913-1320-4EBD-982A-8F211FD6CE64Q36018901-6B0BB680-B8A2-438D-BA45-1FC6D97F2DE5Q36037559-4C8640A7-7DDA-4709-8BE7-C89858A72DF0
P50
name
Gregory D Hussey
@en
Gregory D Hussey
@nl
type
label
Gregory D Hussey
@en
Gregory D Hussey
@nl
prefLabel
Gregory D Hussey
@en
Gregory D Hussey
@nl